PATRICK JAMESON: Open Payments
NPI 1538707393 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,528 in 219 payments from 20 companies in 2025. Trend: 2023 $4,095 · 2024 $6,735 · 2025 $4,528
Food & beverage: $4,266Education: $262
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 21 | $687 |
| Janssen Biotech, Inc. | 16 | $477 |
| PFIZER INC. | 27 | $473 |
| Regeneron Healthcare Solutions, Inc. | 13 | $379 |
| UCB, Inc. | 11 | $290 |
| Arcutis Biotherapeutics, Inc. | 25 | $274 |
| GENZYME CORPORATION | 8 | $269 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $269 |
| ABBVIE INC. | 15 | $255 |
| LEO Pharma Inc. | 13 | $232 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, CIBINQO, Bimzelx, Zoryve, SKYRIZI, ADBRY.
Industry payments across NV — which companies pay providers there.
